APA

Gkritsios P., Hatzimouratidis K., Kazantzidis S., Dimitriadis G., Ioannidis E. & Katsikas V. (20150127). Hexaminolevulinate-guided transurethral resection of non-muscle-invasive bladder cancer does not reduce the recurrence rates after a 2-year follow-up: a prospective randomized trial. : International urology and nephrology.

Chicago

Gkritsios P, Hatzimouratidis K, Kazantzidis S, Dimitriadis G, Ioannidis E and Katsikas V. 20150127. Hexaminolevulinate-guided transurethral resection of non-muscle-invasive bladder cancer does not reduce the recurrence rates after a 2-year follow-up: a prospective randomized trial. : International urology and nephrology.

Harvard

Gkritsios P., Hatzimouratidis K., Kazantzidis S., Dimitriadis G., Ioannidis E. and Katsikas V. (20150127). Hexaminolevulinate-guided transurethral resection of non-muscle-invasive bladder cancer does not reduce the recurrence rates after a 2-year follow-up: a prospective randomized trial. : International urology and nephrology.

MLA

Gkritsios P, Hatzimouratidis K, Kazantzidis S, Dimitriadis G, Ioannidis E and Katsikas V. Hexaminolevulinate-guided transurethral resection of non-muscle-invasive bladder cancer does not reduce the recurrence rates after a 2-year follow-up: a prospective randomized trial. : International urology and nephrology. 20150127.